CIABATTONI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 5.146
EU - Europa 3.689
AS - Asia 3.601
SA - Sud America 354
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 12.839
Nazione #
US - Stati Uniti d'America 5.064
SG - Singapore 1.384
CN - Cina 1.146
UA - Ucraina 811
TR - Turchia 640
IE - Irlanda 605
GB - Regno Unito 564
SE - Svezia 505
FR - Francia 334
DE - Germania 313
BR - Brasile 305
FI - Finlandia 200
IN - India 181
IT - Italia 135
RU - Federazione Russa 130
VN - Vietnam 99
CA - Canada 43
MX - Messico 29
AR - Argentina 24
PL - Polonia 22
KR - Corea 21
BD - Bangladesh 18
HK - Hong Kong 17
ZA - Sudafrica 17
CZ - Repubblica Ceca 15
ES - Italia 12
JP - Giappone 12
IQ - Iraq 10
NL - Olanda 10
EU - Europa 9
ID - Indonesia 9
AT - Austria 8
EC - Ecuador 8
PK - Pakistan 8
IL - Israele 7
IR - Iran 7
SA - Arabia Saudita 7
LT - Lituania 6
JO - Giordania 5
MA - Marocco 5
UZ - Uzbekistan 5
VE - Venezuela 5
CO - Colombia 4
KE - Kenya 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
BE - Belgio 3
EG - Egitto 3
HN - Honduras 3
OM - Oman 3
QA - Qatar 3
RO - Romania 3
UY - Uruguay 3
BB - Barbados 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CL - Cile 2
DZ - Algeria 2
KG - Kirghizistan 2
LB - Libano 2
PH - Filippine 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
IM - Isola di Man 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
TN - Tunisia 1
Totale 12.839
Città #
Singapore 1.068
Jacksonville 857
Chandler 740
Dublin 602
Southend 454
Princeton 314
Izmir 311
Beijing 308
Ashburn 260
Dallas 233
Nanjing 202
Wilmington 184
Santa Clara 170
Los Angeles 155
Cambridge 143
Dearborn 132
Tongling 107
Munich 83
Buffalo 79
New York 76
The Dalles 76
Nanchang 74
Woodbridge 68
Ann Arbor 60
Boardman 58
Shenyang 45
Altamura 40
Council Bluffs 39
Ho Chi Minh City 39
Hebei 34
Kunming 34
Tianjin 34
Grevenbroich 33
São Paulo 33
Washington 33
Helsinki 30
Changsha 28
Jiaxing 28
Turku 28
Houston 25
Moscow 24
Norwalk 24
Brooklyn 23
Seoul 20
Chennai 19
Denver 19
Hanoi 18
Montreal 18
Hangzhou 17
Hong Kong 17
Redondo Beach 17
Warsaw 17
Hefei 16
Augusta 15
Orange 15
Chieti 14
Falls Church 14
Poplar 14
Jinan 13
San Mateo 13
Seattle 12
Tokyo 12
Atlanta 11
Boston 11
Chicago 11
Johannesburg 11
Orem 11
Brno 10
Frankfurt am Main 10
Toronto 10
Mexico City 9
Phoenix 9
Stockholm 9
Changchun 8
Lanzhou 8
Zhengzhou 8
Auburn Hills 7
Belo Horizonte 7
Brasília 7
Leawood 7
Rio de Janeiro 7
Amsterdam 6
Ankara 6
Querétaro 6
Roubaix 6
San Francisco 6
Charlotte 5
London 5
Manchester 5
Mumbai 5
Ningbo 5
Pune 5
Taiyuan 5
Amman 4
Campo Grande 4
Da Nang 4
Goiânia 4
Guayaquil 4
Hackney 4
Haiphong 4
Totale 7.952
Nome #
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 159
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 153
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 138
Amylin inhibits hypothalamic dopamine release. 137
Determinants of platelet activation in hypertensives with microalbuminuria. 137
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 134
Aging increases amyloid beta-peptide-induced 8-iso-prostaglandin F2alpha release from rat brain. 131
Chromatin derived acid peptides inhibit dopamine and norepinephrine release in the hypothalamus. 131
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 129
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 127
Effect of CART peptide-(55-102), leptin and orexin-B on hypothalamicserotonin release. 126
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 126
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 126
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 121
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. 120
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 120
Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during neutrophil granulocytic differentiation and contributes to maturation. 119
8-Isoprostane in exhaled breath condensate (EBC)and excercise-induced bronchoconstriction in asthmatic children and adolescents 118
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 118
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 117
Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X 116
Anterior pituitary cell production of 8-iso-prostaglandin F2alpha. 116
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 115
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 115
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 114
Insulin resistance as a determinant of platelet activation in obese women. 113
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 109
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 109
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 109
Problemi di metodologia per la individuazione del rischio tossicologico. Consiglio Nazionale delle Ricerche 107
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 107
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 106
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 106
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 105
Determinants of platelet activation in hypertensives with microalbuminuria. 105
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 104
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 104
Soluble RAGE in type 2 diabetes: association with oxidative stress. 102
Tachykinin-eicosanoid crosstalk in airway inflammation 101
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. 101
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 101
Determinants of platelet activation in Alzheimer's disease 101
Effects of anthracyclines on hypothalamic dopamine release. 100
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 100
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 100
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 99
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 99
Association between PAI-1 and Oxidative Stress in Android Obesity 99
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 98
Role of Platelet Activation in Dementia 97
Increased exhaled 8-isoprostane in childhood asthma. 97
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 97
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 97
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 97
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 97
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 97
Increased thromboxane biosynthesis in essential thrombocythemia 96
Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. 96
Measurement of 8-isoprostane in exhaled breath condensate. 95
Effect of gherlin and amylin on hypothalamic dopamine, norepinephrine and serotonin release. 94
Insulin resistance as a determinant of platelet activation in obese women 94
Exhaled 8-Isoprostane as an In Vivo Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers 93
Induced sputum, exhaled breath condensate and nasal lavage fluid in electroplating workers exposed to chromium 92
Effects of cocaine- and amphetamine-regulated transcript peptide, leptin and orexins on hypothalamic serotonin release. 92
Drugs, prostaglandins, and renal function. 92
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 92
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 91
Validation of leukotriene B4 measurements in exhaled breath condensate. 89
Anaphylaxis increases 8-iso-PGF2alpha release from guinea-pig lung in vitro 89
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erytrhopoiesis. 89
Determinants of Platelet Activation in Heart Failure. 89
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 89
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 88
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 88
Platelet Activation Markers in Patients with Peripheral Arterial Disease. A Prospective Comparison of Different Platelet Function Tests 88
Identification of 8-iso-prostaglandin (PG) F2alfa in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. 87
Platelet activation in obese women: role of inflammation and oxidant stress. 87
Increased macrothrombocytopenia with distinctive platelet ultrastructural and functional features 86
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype 86
Oxidative stress and platelet activation in children and adolescents with type 1 diabetes: role of interleukin-6 86
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 86
Soluble CD40L as an indicator of platelet Activation in Heart Failure 85
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 85
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 85
Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzima-A inhibitor sinvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. 84
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 83
Enhanced lipid peroxidation and platelet activation in the early stages of type 1 diabetes mellitus. Role of Interleukin-6 and disease duration. 83
Inherited Macrothrombocytopenia with Distinctive Platelet Ultrastructural and Functional Features 82
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 82
Effects of montelukast treatment and withhdrawal on fractional exhaled nitric oxide and lung function in children with asthma 82
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 82
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 82
Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate. 81
Tachykinin-eicosanoid crosstalk in airway inflammation 81
Effects of atorvastatin and rosuvastatin on throboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 81
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 80
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 80
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 79
Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. 78
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 78
Totale 10.134
Categoria #
all - tutte 50.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.649


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021484 0 0 0 0 0 198 2 7 85 151 8 33
2021/2022598 17 7 4 118 71 9 11 43 45 11 78 184
2022/20231.930 159 197 126 222 189 447 115 134 233 19 39 50
2023/2024801 62 33 60 22 48 256 216 25 2 7 9 61
2024/20252.395 149 524 484 28 19 55 20 91 174 64 277 510
2025/20262.166 429 255 407 464 423 188 0 0 0 0 0 0
Totale 13.087